Liposarcomas - 03/10/13
Doi : 10.1016/j.hoc.2013.07.010
Joern Henze, MD, Sebastian Bauer, MD ⁎ 
Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45239, Germany
∗Corresponding author.
Riassunto |
Liposarcoma is one of the most common sarcoma subtypes with a heterogeneous biology and clinical behavior. This article gives a comprehensive overview on clinically relevant aspects of pathology and imaging. Prognostic factors and treatment strategies are discussed for different clinical situations and histologic subtypes. This information will be of value to clinicians and interdisciplinary sarcoma teams.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Liposarcoma, Treatment, Grading, Tumor, Therapy
Mappa
| Funding sources: Dr S. Bauer: Deutsche Krebshilfe, Life-Raft-Group, Novartis. |
|
| Conflict of Interest: Dr S. Bauer: Research support: Novartis; Speakers Honoraria: Novartis, Pfizer, Pharmamar, GSK, Bayer. Dr J. Henze: nil. |
© 2013
Elsevier Inc. Tutti i diritti riservati.
Vol 27 - N° 5
P. 939-955 - ottobre 2013 Ritorno al numero
Articolo precedente
- Treatment of Localized Sarcomas
- Alessandro Gronchi, Chandrajit P. Raut
- Leiomyosarcoma
- César Serrano, Suzanne George
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?